CompletedNot Applicable

Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313

Germany3,785 participantsStarted 2015-10-01

Plain-language summary

This study collects intra- and postoperative data from the patients´charts retrospectively and evaluates retro- and prospectively the rate of posterior capsule opacification (PCO) following implantation of the intraocular lens L 313.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * retrospective: Patients who have undergone a Cataract surgery with Implantation of IOL L313 * prospective: signed informed consent Exclusion Criteria: * capsule rupture * patients with too much travel distance between study center and home

What they're measuring

Percentage of Eyes With Posterior Capsule Opacification Following Implantation of IOL 313 up to 8 Years

Timeframe: up to 8 years

Trial details

NCT IDNCT03184428

SponsorDietrich-Bonhoeffer-Klinikum

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-03-01

Results submitted2019-05-06

View on ClinicalTrials.gov More Posterior Capsule Opacification trials